Binciken Harka
-
Bioendo yana goyan bayan bincike da haɓaka ganowar endotoxin a fagen ƙwayar ƙwayar cuta
A watan Disamba na 2018, Cibiyar bincike ta kirkiro sabbin kwayoyin halitta tare da hadin gwiwar wani babban asibiti da wani babban wurin shakatawa za su kasance cibiyar yanki da ke hade da tarin kwayoyin halitta da adanawa, fasahar kwayar halitta da bincike da haɓaka samfur don inganta sababbin ci gaba a cikin n. ...Kara karantawa -
Bioendo yana da haɗin gwiwa mai zurfi tare da asibitin farko na 3A akan hemodialysis kuma an gayyace shi don shiga cikin taron koli.
Bisa kididdigar da kungiyar kula da asibitocin kasarta ta yi a karshen shekarar 2008, yawan mutanen da suka kamu da cutar a kasar Sin ya kai 10,000 a shekara ya kai kashi 52.9 cikin 100, wanda kashi 89.5 cikin 100 na marasa lafiya sun karbi jimillar marasa lafiya 102,863 na tsawon lokaci, tare da yaduwa. 79.1/100 rashi...Kara karantawa -
Bioendo ya cimma dogon lokaci tare da cibiyoyi da ƙungiyoyi daban-daban a duk faɗin ƙasar kan horon aseptic don taimakawa haɓaka horon aseptic.
A cikin Yuli 2015, CFDA ta ba da takaddun da suka dace, suna buƙatar masana'antun su sami damar da yanayi don gwajin haifuwa, iyakokin microbial da ingantattun sarrafawa, kuma waɗanda ke tsunduma cikin aikin da ke shafar ingancin samfur ya kamata su sha horon fasaha daidai kuma suna da dacewa da ...Kara karantawa -
Tare da taimakon Bioendo, samfurin rigakafin GMP na farko na kasar Sin ya amince da amfani da EU kuma an ƙaddamar da shi a cikin kasuwar EU.
A karshen shekarar 2019, sabuwar annobar kambi ta yi tsanani.A cikin Disamba 2020, sabon maganin rigakafin cutar kambi wanda sanannen kamfanin biopharmaceutical ya samar kuma ya samar da kashi 86% akan kamuwa da kwayar cutar, kuma adadin canza garkuwar jikin mutum ya kasance 99%, wanda zai iya zama 100% kafin…Kara karantawa
